Cleared Special

Huvitz Imaging System (K191615) - FDA 510(k) Clearance

Class II Ophthalmic device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2019
Decision
30d
Days
Class 2
Risk

K191615 is an FDA 510(k) clearance for the Huvitz Imaging System. Classified as System, Image Management, Ophthalmic (product code NFJ), Class II - Special Controls.

Submitted by Huvitz Co., Ltd. (Anyang-Si, Dongan-Gu, KR). The FDA issued a Cleared decision on July 18, 2019 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 892.2050 - the FDA ophthalmic device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Huvitz Co., Ltd. devices

Submission Details

510(k) Number K191615 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 18, 2019
Decision Date July 18, 2019
Days to Decision 30 days
Submission Type Special
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
80d faster than avg
Panel avg: 110d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code NFJ System, Image Management, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Consultant

Mtechgroup
Dave Kim

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NFJ System, Image Management, Ophthalmic

All 25
Devices cleared under the same product code (NFJ) and FDA review panel - the closest regulatory comparables to K191615.
Glaucoma Module
K200954 · Topcon Healthcare Solutions, Inc. · Aug 2020
CONTINUUM PACS
K200385 · Integrated Ophthalmic Systems, Inc. · Mar 2020
OVision Imaging System
K200275 · Ophthalmic Labs, Inc. · Mar 2020
KOWA VK-2s
K190056 · Kowa Co. Ltd. Chofu · Feb 2019
Afina
K181501 · Neurovision Imaging, LLC · Nov 2018
Retina Workplace
K182318 · Carl Zeiss Meditec, Inc. · Oct 2018